The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
MeSH Review

Multiple Sclerosis

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

Disease relevance of Multiple Sclerosis


Psychiatry related information on Multiple Sclerosis


High impact information on Multiple Sclerosis


Chemical compound and disease context of Multiple Sclerosis


Biological context of Multiple Sclerosis


Anatomical context of Multiple Sclerosis


Gene context of Multiple Sclerosis


Analytical, diagnostic and therapeutic context of Multiple Sclerosis





  1. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Gately, M.K., Renzetti, L.M., Magram, J., Stern, A.S., Adorini, L., Gubler, U., Presky, D.H. Annu. Rev. Immunol. (1998) [Pubmed]
  2. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens. Weiner, H.L., Friedman, A., Miller, A., Khoury, S.J., al-Sabbagh, A., Santos, L., Sayegh, M., Nussenblatt, R.B., Trentham, D.E., Hafler, D.A. Annu. Rev. Immunol. (1994) [Pubmed]
  3. The effect of corticosteroids for acute optic neuritis on the subsequent development of multiple sclerosis. The Optic Neuritis Study Group. Beck, R.W., Cleary, P.A., Trobe, J.D., Kaufman, D.I., Kupersmith, M.J., Paty, D.W., Brown, C.H. N. Engl. J. Med. (1993) [Pubmed]
  4. MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction. Swanberg, M., Lidman, O., Padyukov, L., Eriksson, P., Akesson, E., Jagodic, M., Lobell, A., Khademi, M., Börjesson, O., Lindgren, C.M., Lundman, P., Brookes, A.J., Kere, J., Luthman, H., Alfredsson, L., Hillert, J., Klareskog, L., Hamsten, A., Piehl, F., Olsson, T. Nat. Genet. (2005) [Pubmed]
  5. Glutamate excitotoxicity in a model of multiple sclerosis. Pitt, D., Werner, P., Raine, C.S. Nat. Med. (2000) [Pubmed]
  6. Translational control of inducible nitric oxide synthase expression by arginine can explain the arginine paradox. Lee, J., Ryu, H., Ferrante, R.J., Morris, S.M., Ratan, R.R. Proc. Natl. Acad. Sci. U.S.A. (2003) [Pubmed]
  7. Altered decision-making in multiple sclerosis: a sign of impaired emotional reactivity? Kleeberg, J., Bruggimann, L., Annoni, J.M., van Melle, G., Bogousslavsky, J., Schluep, M. Ann. Neurol. (2004) [Pubmed]
  8. Disease activity and emotional state in multiple sclerosis. Dalos, N.P., Rabins, P.V., Brooks, B.R., O'Donnell, P. Ann. Neurol. (1983) [Pubmed]
  9. Inhibition of p75 tumor necrosis factor receptor by antisense oligonucleotides increases hypoxic injury and beta-amyloid toxicity in human neuronal cell line. Shen, Y., Li, R., Shiosaki, K. J. Biol. Chem. (1997) [Pubmed]
  10. Event-related brain potential evidence for a verbal working memory deficit in multiple sclerosis. Ruchkin, D.S., Grafman, J., Krauss, G.L., Johnson, R., Canoune, H., Ritter, W. Brain (1994) [Pubmed]
  11. A predominant role for the HLA class II region in the association of the MHC region with multiple sclerosis. Lincoln, M.R., Montpetit, A., Cader, M.Z., Saarela, J., Dyment, D.A., Tiislar, M., Ferretti, V., Tienari, P.J., Sadovnick, A.D., Peltonen, L., Ebers, G.C., Hudson, T.J. Nat. Genet. (2005) [Pubmed]
  12. Vaccinations and the risk of relapse in multiple sclerosis. Vaccines in Multiple Sclerosis Study Group. Confavreux, C., Suissa, S., Saddier, P., Bourdès, V., Vukusic, S. N. Engl. J. Med. (2001) [Pubmed]
  13. PTPRC (CD45) is not associated with the development of multiple sclerosis in U.S. patients. Barcellos, L.F., Caillier, S., Dragone, L., Elder, M., Vittinghoff, E., Bucher, P., Lincoln, R.R., Pericak-Vance, M., Haines, J.L., Weiss, A., Hauser, S.L., Oksenberg, J.R. Nat. Genet. (2001) [Pubmed]
  14. A point mutation in PTPRC is associated with the development of multiple sclerosis. Jacobsen, M., Schweer, D., Ziegler, A., Gaber, R., Schock, S., Schwinzer, R., Wonigeit, K., Lindert, R.B., Kantarci, O., Schaefer-Klein, J., Schipper, H.I., Oertel, W.H., Heidenreich, F., Weinshenker, B.G., Sommer, N., Hemmer, B. Nat. Genet. (2000) [Pubmed]
  15. A putative vulnerability locus to multiple sclerosis maps to 5p14-p12 in a region syntenic to the murine locus Eae2. Kuokkanen, S., Sundvall, M., Terwilliger, J.D., Tienari, P.J., Wikström, J., Holmdahl, R., Pettersson, U., Peltonen, L. Nat. Genet. (1996) [Pubmed]
  16. Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH. Hauser, S.L., Dawson, D.M., Lehrich, J.R., Beal, M.F., Kevy, S.V., Propper, R.D., Mills, J.A., Weiner, H.L. N. Engl. J. Med. (1983) [Pubmed]
  17. Does 77C-->G in PTPRC modify autoimmune disorders linked to the major histocompatibility locus? Vorechovsky, I., Kralovicova, J., Tchilian, E., Masterman, T., Zhang, Z., Ferry, B., Misbah, S., Chapel, H., Webster, D., Hellgren, D., Anvret, M., Hillert, J., Hammarstrom, L., Beverley, P.C. Nat. Genet. (2001) [Pubmed]
  18. Lipid microarrays identify key mediators of autoimmune brain inflammation. Kanter, J.L., Narayana, S., Ho, P.P., Catz, I., Warren, K.G., Sobel, R.A., Steinman, L., Robinson, W.H. Nat. Med. (2006) [Pubmed]
  19. An endogenous pentapeptide acting as a sodium channel blocker in inflammatory autoimmune disorders of the central nervous system. Brinkmeier, H., Aulkemeyer, P., Wollinsky, K.H., Rüdel, R. Nat. Med. (2000) [Pubmed]
  20. A complete genomic screen for multiple sclerosis underscores a role for the major histocompatability complex. The Multiple Sclerosis Genetics Group. Haines, J.L., Ter-Minassian, M., Bazyk, A., Gusella, J.F., Kim, D.J., Terwedow, H., Pericak-Vance, M.A., Rimmler, J.B., Haynes, C.S., Roses, A.D., Lee, A., Shaner, B., Menold, M., Seboun, E., Fitoussi, R.P., Gartioux, C., Reyes, C., Ribierre, F., Gyapay, G., Weissenbach, J., Hauser, S.L., Goodkin, D.E., Lincoln, R., Usuku, K., Oksenberg, J.R. Nat. Genet. (1996) [Pubmed]
  21. Measles virus nucleotide sequences: detection by hybridization in situ. Haase, A.T., Ventura, P., Gibbs, C.J., Tourtellotte, W.W. Science (1981) [Pubmed]
  22. Regulation of ZAP-70 activation and TCR signaling by two related proteins, Sts-1 and Sts-2. Carpino, N., Turner, S., Mekala, D., Takahashi, Y., Zang, H., Geiger, T.L., Doherty, P., Ihle, J.N. Immunity (2004) [Pubmed]
  23. Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones. Wucherpfennig, K.W., Sette, A., Southwood, S., Oseroff, C., Matsui, M., Strominger, J.L., Hafler, D.A. J. Exp. Med. (1994) [Pubmed]
  24. Genetic susceptibility to multiple sclerosis linked to myelin basic protein gene. Colover, J. Lancet (1993) [Pubmed]
  25. Association between tumor necrosis factor-alpha and disease progression in patients with multiple sclerosis. Sharief, M.K., Hentges, R. N. Engl. J. Med. (1991) [Pubmed]
  26. In vivo activated T lymphocytes in the peripheral blood and cerebrospinal fluid of patients with multiple sclerosis. Hafler, D.A., Fox, D.A., Manning, M.E., Schlossman, S.F., Reinherz, E.L., Weiner, H.L. N. Engl. J. Med. (1985) [Pubmed]
  27. Myelin failure in multiple sclerosis: breaking the spell of Notch. Hohlfeld, R. Nat. Med. (2002) [Pubmed]
  28. Human endogenous retrovirus glycoprotein-mediated induction of redox reactants causes oligodendrocyte death and demyelination. Antony, J.M., van Marle, G., Opii, W., Butterfield, D.A., Mallet, F., Yong, V.W., Wallace, J.L., Deacon, R.M., Warren, K., Power, C. Nat. Neurosci. (2004) [Pubmed]
  29. Stimulation of oligodendroglial proliferation and maturation by interleukin-2. Benveniste, E.N., Merrill, J.E. Nature (1986) [Pubmed]
  30. Multiple sclerosis: re-expression of a developmental pathway that restricts oligodendrocyte maturation. John, G.R., Shankar, S.L., Shafit-Zagardo, B., Massimi, A., Lee, S.C., Raine, C.S., Brosnan, C.F. Nat. Med. (2002) [Pubmed]
  31. Expression of costimulatory molecules B7-1 (CD80), B7-2 (CD86), and interleukin 12 cytokine in multiple sclerosis lesions. Windhagen, A., Newcombe, J., Dangond, F., Strand, C., Woodroofe, M.N., Cuzner, M.L., Hafler, D.A. J. Exp. Med. (1995) [Pubmed]
  32. A critical role for lymphotoxin in experimental allergic encephalomyelitis. Suen, W.E., Bergman, C.M., Hjelmström, P., Ruddle, N.H. J. Exp. Med. (1997) [Pubmed]
  33. Modifications of myelin basic protein in DM20 transgenic mice are similar to those in myelin basic protein from multiple sclerosis. Mastronardi, F.G., Mak, B., Ackerley, C.A., Roots, B.I., Moscarello, M.A. J. Clin. Invest. (1996) [Pubmed]
  34. A second major histocompatibility complex susceptibility locus for multiple sclerosis. Yeo, T.W., De Jager, P.L., Gregory, S.G., Barcellos, L.F., Walton, A., Goris, A., Fenoglio, C., Ban, M., Taylor, C.J., Goodman, R.S., Walsh, E., Wolfish, C.S., Horton, R., Traherne, J., Beck, S., Trowsdale, J., Caillier, S.J., Ivinson, A.J., Green, T., Pobywajlo, S., Lander, E.S., Pericak-Vance, M.A., Haines, J.L., Daly, M.J., Oksenberg, J.R., Hauser, S.L., Compston, A., Hafler, D.A., Rioux, J.D., Sawcer, S. Ann. Neurol. (2007) [Pubmed]
  35. Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis. Lock, C., Hermans, G., Pedotti, R., Brendolan, A., Schadt, E., Garren, H., Langer-Gould, A., Strober, S., Cannella, B., Allard, J., Klonowski, P., Austin, A., Lad, N., Kaminski, N., Galli, S.J., Oksenberg, J.R., Raine, C.S., Heller, R., Steinman, L. Nat. Med. (2002) [Pubmed]
  36. Spontaneous regression of primary autoreactivity during chronic progression of experimental autoimmune encephalomyelitis and multiple sclerosis. Tuohy, V.K., Yu, M., Yin, L., Kawczak, J.A., Kinkel, R.P. J. Exp. Med. (1999) [Pubmed]
  37. Clonal expansions of CD8(+) T cells dominate the T cell infiltrate in active multiple sclerosis lesions as shown by micromanipulation and single cell polymerase chain reaction. Babbe, H., Roers, A., Waisman, A., Lassmann, H., Goebels, N., Hohlfeld, R., Friese, M., Schröder, R., Deckert, M., Schmidt, S., Ravid, R., Rajewsky, K. J. Exp. Med. (2000) [Pubmed]
  38. The heat-stable antigen determines pathogenicity of self-reactive T cells in experimental autoimmune encephalomyelitis. Bai, X.F., Liu, J.Q., Liu, X., Guo, Y., Cox, K., Wen, J., Zheng, P., Liu, Y. J. Clin. Invest. (2000) [Pubmed]
  39. Does virus persist in the uvea in multiple sclerosis, as in canine distemper encephalomyelitis? Summers, B.A., Greisen, H.A., Appel, M.J. Lancet (1983) [Pubmed]
WikiGenes - Universities